Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism.

Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism. Crit Pathw Cardiol. 2011 Jun; 10(2):84-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.